Endothelial sialyl Lewis X-modified integrin α3 drives fatty-acid metabolic reprogramming to shape Th17 plasticity in bladder cancer

Abstract Tumor endothelial cells (TECs) are active regulators of the tumor immune microenvironment, and their surfaces are enriched with diverse glycans. However, the influence of endothelial glycosylation on immune regulation remains poorly understood. Here, we show that sialyl Lewis X (sLeX) glycosylation of integrin α3 (ITGA3) in endothelial cells (ECs) promotes endothelial-to-mesenchymal transition (Endo-MT) by stabilizing Slug and repressing CDH5 transcription via the EGFR-AKT-GSK3β axis. This process is accompanied by downregulation of fatty aldehyde dehydrogenase (FALDH/ALDH3A2), with impaired fatty acid oxidation and decreased mitochondrial ROS. Reduced ROS levels attenuated the production of the pro-inflammatory cytokines IL-1β and IL-6, enhanced TGF-β production, and reduced Th1-like Th17 responses, thereby favoring Treg-like Th17 phenotypes. Functionally, endothelial sLeX-modified ITGA3 reshapes the immune microenvironment toward a regulatory immune phenotype. Collectively, these findings identify a link between endothelial glycosylation, metabolic reprogramming, and immune regulation, and suggest that sLeX-modified ITGA3 contributes to endothelial-mediated modulation of Th17-associated responses in bladder cancer.

Authors

Institutions

Publication Details

Journal
Cell Death and Disease
Published
2026-11-14
DOI
https://doi.org/10.1038/s41419-026-09408-3
Primary Topic
Glycosylation and Glycoproteins Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Endothelial sialyl Lewis X-modified integrin α3 drives fatty-acid metabolic reprogramming to shape Th17 plasticity in bladder cancer

Feng Guan
Cell Death and Disease
Glycosylation and Glycoproteins Research
article

Endothelial sialyl Lewis X-modified integrin α3 drives fatty-acid metabolic reprogramming to shape Th17 plasticity in bladder cancer

Feng Guan
article en

Abstract

Abstract Tumor endothelial cells (TECs) are active regulators of the tumor immune microenvironment, and their surfaces are enriched with diverse glycans. However, the influence of endothelial glycosylation on immune regulation remains poorly understood. Here, we show that sialyl Lewis X (sLeX) glycosylation of integrin α3 (ITGA3) in endothelial cells (ECs) promotes endothelial-to-mesenchymal transition (Endo-MT) by stabilizing Slug and repressing CDH5 transcription via the EGFR-AKT-GSK3β axis. This process is accompanied by downregulation of fatty aldehyde dehydrogenase (FALDH/ALDH3A2), with impaired fatty acid oxidation and decreased mitochondrial ROS. Reduced ROS levels attenuated the production of the pro-inflammatory cytokines IL-1β and IL-6, enhanced TGF-β production, and reduced Th1-like Th17 responses, thereby favoring Treg-like Th17 phenotypes. Functionally, endothelial sLeX-modified ITGA3 reshapes the immune microenvironment toward a regulatory immune phenotype. Collectively, these findings identify a link between endothelial glycosylation, metabolic reprogramming, and immune regulation, and suggest that sLeX-modified ITGA3 contributes to endothelial-mediated modulation of Th17-associated responses in bladder cancer.

Cell Death and Disease
Ministry of Education of the People's Republic of China (CN), Northwest University (CN)
National Natural Science Foundation of China
Good health and well-being
Glycosylation and Glycoproteins Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon